| MeSH term | MeSH ID | Detail |
|---|---|---|
| Hemolysis | D006461 | 131 associated lipids |
| Otitis Externa | D010032 | 8 associated lipids |
| Burns | D002056 | 34 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Peritonitis | D010538 | 38 associated lipids |
| Anemia, Sickle Cell | D000755 | 34 associated lipids |
| Vaginitis | D014627 | 6 associated lipids |
| Cystic Fibrosis | D003550 | 65 associated lipids |
| Hypertension | D006973 | 115 associated lipids |
| Dermatomycoses | D003881 | 17 associated lipids |
| Pregnancy Complications, Infectious | D011251 | 11 associated lipids |
| Aspergillosis | D001228 | 5 associated lipids |
| Leishmaniasis | D007896 | 19 associated lipids |
| HIV Seropositivity | D006679 | 15 associated lipids |
| Influenza, Human | D007251 | 11 associated lipids |
| Vaginosis, Bacterial | D016585 | 10 associated lipids |
| Candidiasis, Oral | D002180 | 11 associated lipids |
| Mycoses | D009181 | 18 associated lipids |
| Gonorrhea | D006069 | 7 associated lipids |
| Xerostomia | D014987 | 6 associated lipids |
Nystatin A3
Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.
Cross Reference
Introduction
To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Nystatin A3?
Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Nystatin A3
PubChem Associated disorders and diseases
What pathways are associated with Nystatin A3
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Nystatin A3?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Nystatin A3?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Nystatin A3?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Nystatin A3?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Nystatin A3?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Nystatin A3
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Khan MA et al. | Immune stimulating and therapeutic potential of tuftsin-incorporated nystatin liposomes against Cryptococcus neoformans in leukopenic BALB/C mice. | 2012 | FEMS Immunol. Med. Microbiol. | pmid:22612788 |
| Gerstein AC et al. | Parallel genetic changes and nonparallel gene-environment interactions characterize the evolution of drug resistance in yeast. | 2012 | Genetics | pmid:22714405 |
| Mima EG et al. | Comparison of Photodynamic Therapy versus conventional antifungal therapy for the treatment of denture stomatitis: a randomized clinical trial. | 2012 | Clin. Microbiol. Infect. | pmid:22731617 |
| Kalema N et al. | Oral antimicrobial rinse to reduce mycobacterial culture contamination among tuberculosis suspects in Uganda: a prospective study. | 2012 | PLoS ONE | pmid:22808020 |
| Caliceti C et al. | Effect of plasma membrane cholesterol depletion on glucose transport regulation in leukemia cells. | 2012 | PLoS ONE | pmid:22859971 |
| Ocerin-Guerra I et al. | Nystatin-induced acute generalized exanthematous pustulosis. | 2012 | Actas Dermosifiliogr | pmid:23149047 |
| Castón JJ et al. | [Clinical factors associated with invasive pulmonary aspergillosis in patients with chronic pneumopathies and respiratory isolation of Aspergillus spp]. | 2012 | Med Clin (Barc) | pmid:23103103 |
| Seipke RF et al. | Isolating antifungals from fungus-growing ant symbionts using a genome-guided chemistry approach. | 2012 | Meth. Enzymol. | pmid:23084933 |
| Kaczorowska-Hac B et al. | Methemoglobinemia in postchemotherapy stomatitis topical treatment: 2 pediatric cases. | 2012 | J. Pediatr. Hematol. Oncol. | pmid:21900833 |
| Agwu E et al. | Distribution of yeast species associated with oral lesions in HIV-infected patients in Southwest Uganda. | 2012 | Med. Mycol. | pmid:21905950 |
| Hingston CD et al. | Impact of nystatin on Candida and the oral microbiome. | 2012 | Crit Care | pmid:22827886 |
| Xu L et al. | Epirubicin enhances TRAIL-induced apoptosis in gastric cancer cells by promoting death receptor clustering in lipid rafts. | 2011 May-Jun | Mol Med Rep | pmid:21468584 |
| Brito GN et al. | In vitro antifungal susceptibility of Candida spp. oral isolates from HIV-positive patients and control individuals. | 2011 Jan-Feb | Braz Oral Res | pmid:21271179 |
| El-Ridy MS et al. | Niosomes as a potential drug delivery system for increasing the efficacy and safety of nystatin. | 2011 | Drug Dev Ind Pharm | pmid:21707323 |
| Zerbib C et al. | One-pot synthesis of a new antifungal polymerisable monomer and its characterisation by coordination-ion spray mass spectrometry. | 2011 | Rapid Commun. Mass Spectrom. | pmid:21710593 |
| Messier C and Grenier D | Effect of licorice compounds licochalcone A, glabridin and glycyrrhizic acid on growth and virulence properties of Candida albicans. | 2011 | Mycoses | pmid:21615543 |
| Mayercik VA et al. | Fungal endophthalmitis developing in asthmatic individuals treated with inhaled corticosteroids. | 2011 | Arch. Ophthalmol. | pmid:21746988 |
| Pupe CG et al. | Preparation and evaluation of antimicrobial activity of nanosystems for the control of oral pathogens Streptococcus mutans and Candida albicans. | 2011 | Int J Nanomedicine | pmid:22114490 |
| Valitova JN et al. | Effects of sterol-binding agent nystatin on wheat roots: the changes in membrane permeability, sterols and glycoceramides. | 2011 | Phytochemistry | pmid:21726881 |
| Ebert S et al. | Candida esophagitis as the cause of swallowing disturbances in an 85-year-old patient with myasthenia gravis. | 2011 | Z Gerontol Geriatr | pmid:21732154 |